Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1015 | 1015 | 1081 | 1238 | 1368 | 1861 |
Fund Return | 1.5% | 1.5% | 8.1% | 7.38% | 6.47% | 6.41% |
Place in category | 371 | 371 | 230 | 146 | 39 | 33 |
% in Category | 72 | 72 | 45 | 32 | 12 | 12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UK Equity Income Fund Retail Income | 140.26M | -2.33 | 7.02 | 4.93 | ||
UK Equity Income Fund Institutional | 90.63M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Z Income GBP | 684.66M | 1.50 | 7.39 | 6.42 | ||
UK Equity Income Fund Retail Accumu | 117.6M | 1.30 | 6.55 | 5.58 | ||
Select Fund Z Accumulation GBP | 999.09M | 8.04 | 7.99 | 9.80 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 1.92B | 5.82 | 8.22 | 6.86 | ||
TB Evenlode Income B Income | 3.33B | 0.66 | 7.02 | 8.54 | ||
UK Equity Income Fund Institutional | 90.1M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Retail Income | 139.63M | -2.33 | 7.02 | 4.93 | ||
UK Equity Income Fund Z Income GBP | 681.6M | 1.50 | 7.39 | 6.42 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Imperial Brands | GB0004544929 | 6.73 | 1,840.00 | +0.30% | |
GSK plc | GB00BN7SWP63 | 5.77 | 1,700.00 | -0.29% | |
Unilever | GB00B10RZP78 | 4.93 | 48.60 | +0.21% | |
Pearson | GB0006776081 | 4.49 | 968.20 | +0.08% | |
RS PLC | GB0003096442 | 3.99 | 746.50 | +1.01% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review